[1] Wu T, Wang P, Zhang T, et al. Comparison of two-dimensional shear wave elastography and real-time tissue elastography for assessing liver fibrosis in chronic hepatitis B. Dig Dis, 2016,34:640-649. [2] 谢春艳,胡景玉,牟娜,等.APRI对慢性乙型肝炎肝脏炎症和纤维化程度的预测性能评价. 中国免疫学杂志,2020,36:210-214. [3] 中华医学会感染病学分会,中华医学会肝病学分会.慢性乙型肝炎防治指南(2019年版). 中华肝脏病杂志,2019,27:938-961. [4] 中华医学会肝病学分会,中华医学会消化病学分会,中华医学会感染病学分会.肝纤维化诊断及治疗共识(2019年). 肝脏,2019,24:975-983,996. [5] Abrams GA, Jamal H, Deeter WT, et al. LOGIQ E9 shear wave elastrography for detection of liver fibrosis in patients with chronic hepatitis C virus.South Med J, 2016, 109:730-734. [6] Leit Ohs, Doblas S, Garteiser P, et al. Hepatic fibrosis, inflammation, and steatosis: influence on the MR viscoelastic and diffusion parameters in patients with chronic liver disease. Radiology, 2017,283:98-107. [7] Ura K, Furusyo N, Ogawa E, et al. Serum WFA(+) -M2BP is a non-invasive liver fibrosis marker that can predict the efficacy of direct-acting anti-viral-based triple therapy for chronic hepatitis C. Aliment Pharmacol Ther, 2018,43:114-124. [8] Wang HQ, Jin KP, Zeng MS, et al. Assessing liver fibrosis in chronic hepatitis B using MR extracellular volume measurements: Comparison with serum fibrosis indices. Magne Reson Imaging, 2019,59:39-45. [9] 王越,刘学民,王博, 等.术前天冬氨酸转氨酶/血小板比值指数对肝细胞癌患者手术切除后并发症的预测价值.中华肝胆外科杂志,2016,22:289-293. [10] Mai RY, Ye JZ, Long ZR, et al. Preoperative aspartate aminotransferase-to-platelet-ratio index as a predictor of posthepatectomy liver failure for resectable hepatocellular carcinoma. Cancer Manag Res, 2019, 12:1401-1414. [11] Drees JC, Soora W, Ready JB, et al. Serum fibrosis marker panels FIB-4 index and aspartate aminotransferase (AST)-to-platelet ratio index (APRI) are equivalent to AST alone at predicting liver fibrosis in a cohort of 1731 patients infected with hepatitis C virus. J Appl Lab Med, 2017,2:76-85. [12] Kim WR, Berg T, Asselah T, et al. Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.J Hepatol, 2016, 64:773-780. [13] 林秀梅, 朱冬林, 陈文思. 肝纤维化四项检查与天冬氨酸氨基转移酶和血小板比率联合检测在诊断慢性乙型肝炎纤维化中的意义.中国卫生检验杂志,2017,27:1136-1138. |